{"disease":{"id":"functional-pancreatic-neuroendocrine-tumor","name":"functional pancreatic neuroendocrine tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02420691","title":"Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT05566093","title":"EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Guangxi Medical University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}